In another study, a high level of expression of apoptosis activator tBid  in breast cancer cells was achieved via the use of a hybrid promoter consisting of promoters of the human survinin gene and the gene encoding glycoprotein mucin; its expression increased in breast cancer cells [91]. The gene discussed is BID; the disease is breast carcinoma.